Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
ATRIPLA® is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
- generic_name
- efavirenz, emtricitabine, and tenofovir disoproxil fumarate
- product_names
- efavirenz, emtricitabine, and tenofovir disoproxil fumarate
- ndc
- 54868-5643, 15584-0101, 54868-5643-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en